Recent events
Recent events tied to this brand in public sources.
Back to profile38 entries · Page 1 of 2
2026
Siemens Healthineers and Alibaba Damo Academy sign strategic cooperation agreement
Siemens Healthineers and Alibaba Damo Academy signed a strategic cooperation agreement to combine photon-counting CT imaging technology and medical AI capabilities and explore early screening for cancer and cardiovascular diseases.
2026
Siemens Healthineers and Alibaba Damo Academy launch multicenter pancreatic cancer screening research project
Siemens Healthineers and Alibaba Damo Academy jointly participated in the launch of a multicenter research project on AI-assisted early screening and diagnosis of pancreatic cancer, led by Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital and involving multiple medical institutions in China.
2026
NVIDIA and Siemens Healthineers collaborate on adaptive radiotherapy
NVIDIA and Siemens Healthineers announced a collaboration to explore adaptive radiotherapy using agentic AI, patient-specific simulation and robotic intelligence. Siemens Healthineers’ Varian cancer care business is involved.
2024
Qure.ai receives Siemens Healthineers Startup Award 2024
Qure.ai received a Startup Award from Siemens Healthineers, recognizing its contributions to improving diagnosis of tuberculosis, stroke, and musculoskeletal conditions through AI solutions.
2024
Siemens Healthineers China and Cedars-Sinai Medical Center sign cooperation memorandum
Siemens Healthineers China and Cedars-Sinai Medical Center signed a memorandum of understanding to deepen international exchange and cooperation in areas including medical education resource sharing, innovation, telemedicine and hospital management.
2024
Siemens Healthineers appoints Kalavathi GV to lead its Development Center
Siemens Healthineers appointed Kalavathi GV as Head of Development Center and executive director at Siemens Healthineers India, effective July 1, 2024. She will lead more than 3,500 Development Center employees in India and Slovakia.
2024
Siemens Healthineers launches Cinematic Reality app for Apple Vision Pro
Siemens Healthineers launched the Cinematic Reality app for Apple Vision Pro. The app lets users view and interact with immersive renderings of human anatomy captured through medical scans, and was available on the Apple App Store.
2023
Siemens Healthineers China and Sun Yat-sen Memorial Hospital sign strategic cooperation agreement
Siemens Healthineers China and Sun Yat-sen Memorial Hospital signed a strategic cooperation agreement to explore research and clinical translation of metaverse-visualized surgery for anterolateral thigh flap transplantation, develop related tools, and collaborate on academic papers, patent applications, and research projects.
2023
Siemens Healthineers inaugurates MRI manufacturing facility in Bengaluru
Siemens Healthineers inaugurated a new MRI manufacturing facility in Bengaluru, India. The facility will manufacture MAGNETOM Free.Star.
2023
Oncimmune and Siemens Healthineers announce lung nodule assessment collaboration
Oncimmune announced a collaboration with Siemens Healthineers combining the EarlyCDT Lung blood test with AI-Rad Companion chest CT to improve malignancy risk assessment of indeterminate pulmonary nodules. The collaboration will also access data from the ECLS trial.
2022
ClariCT.AI becomes available through Siemens Healthineers’ Digital Marketplace
ClariPi announced that its ClariCT.AI software was available through Siemens Healthineers’ Digital Marketplace, on syngo.via, giving users access to explore, trial and deploy the application.
2022
Siemens Healthineers names leader for new Asia-Pacific region
Siemens Healthineers announced that Vy Tran would lead the newly established Asia-Pacific region excluding China, including Japan.
2022
Siemens Healthineers announces two respiratory diagnostic tests
Siemens Healthineers announced two new tests: a CE-marked PCR combination test for COVID-19, influenza A and B, and respiratory syncytial virus, and the CLINITEST COVID-19 and influenza antigen rapid test.
2022
Healthway Cancer Care Center partners with Siemens Healthineers
Healthway Cancer Care Center partnered with Siemens Healthineers, which will provide technical expertise and diagnostic and therapeutic imaging technologies as the center prepares to open its cancer facility.
2022
Shanghai Electric and Siemens Healthineers sign strategic cooperation agreement
Shanghai Electric and Siemens Healthineers signed a strategic cooperation agreement to advance localization and innovation in Chinese medical equipment and cooperate across business systems, product development, and after-sales service.
2022
Siemens Healthineers and Junxin Medical announce strategic partnership
Siemens Healthineers announced a strategic partnership with Guangdong Junxin Medical Technology Services to combine resources and develop cancer-care services in the Greater Bay Area.
2022
Siemens Healthineers launches Syngo Carbon in China
Siemens Healthineers launched its Syngo Carbon enterprise healthcare digital platform in China, offering functions including medical image storage and viewing, artificial intelligence, clinical-data management and workflow management.
2022
Siemens Healthineers announces a syngo.via software upgrade
Siemens Healthineers announced that syngo.via, the intelligent image post-processing software integrated into Syngo Carbon, would be upgraded to the latest version. The announcement described enhanced image-reading and clinical decision-support capabilities, as well as integration with third-party software.
2022
Ascend announces strategic relationship with Siemens Healthineers
Ascend announced a strategic relationship with Siemens Healthineers intended to increase testing capacity at Ascend’s new laboratory in Sunnyvale, California. The laboratory is expected to open in the second quarter of 2022.
2021
ScreenPoint Medical raises $28 million in Series C funding
ScreenPoint Medical announced that it had raised $28 million in Series C funding, led by Insight Partners, with participation from existing investors and University Radiology Group. The company said the funding would support commercial growth, research and development, and product-portfolio expansion.